Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-06

FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

The FDA approves a supplemental application for fenofibric acid submitted by Amneal Pharmaceuticals of New York LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fenofibric acid (fenofibric acid)

Snippet

SUPPL AP for FENOFIBRIC ACID (FENOFIBRIC ACID)